Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial. - Petrelli, F.; Rulli, E.; Labianca, R.; Lonardi, S.; Rosati, G.; Dotti, K.; Ronzoni, M.; Pella, N.; Pusceddu, V.; Banzi, M.; Zampino, M.G.; Yasmina, M.; et al. (Annals of Oncology, 2021)